Free Trial

Amplifon (OTCMKTS:AMFPF) Releases Quarterly Earnings Results

Amplifon logo with Medical background

Key Points

  • Amplifon reported a quarterly earnings per share of $0.25, with a net margin of 5.90% and a return on equity of 13.77%.
  • The stock increased by 1.2% following the earnings release, opening at $17.46 with a market capitalization of $3.94 billion.
  • Morgan Stanley has restated an "overweight" rating on Amplifon, indicating strong confidence in the company's future performance.
  • Want stock alerts on Amplifon? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Amplifon (OTCMKTS:AMFPF - Get Free Report) released its quarterly earnings data on Thursday. The company reported $0.25 earnings per share for the quarter, Zacks reports. Amplifon had a net margin of 5.90% and a return on equity of 13.77%.

Amplifon Stock Up 1.2%

Shares of AMFPF opened at $17.46 on Friday. Amplifon has a 52 week low of $16.97 and a 52 week high of $29.33. The firm has a market cap of $3.94 billion, a P/E ratio of 25.68 and a beta of 0.53. The firm's 50-day simple moving average is $22.80 and its 200 day simple moving average is $23.01. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.54 and a current ratio of 0.62.

Analysts Set New Price Targets

Separately, Morgan Stanley restated an "overweight" rating on shares of Amplifon in a research note on Wednesday, June 25th.

Get Our Latest Stock Report on AMFPF

About Amplifon

(Get Free Report)

Amplifon S.p.A. engages in the distribution of hearing solutions and the fitting of customized products that help people rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Ampli-easy, Ampli-connect, Ampli-energy, and Ampli-mini hearing devices.

See Also

Earnings History for Amplifon (OTCMKTS:AMFPF)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amplifon Right Now?

Before you consider Amplifon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amplifon wasn't on the list.

While Amplifon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines